🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/06/1992 | 23,86 | 23,91 | 23,38 | 23,62 | -1,98% | 2,25% | 6.704.266 |
| 22/06/1992 | 23,32 | 24,15 | 23,26 | 24,09 | +4,66% | 3,84% | 7.440.800 |
| 19/06/1992 | 22,84 | 23,20 | 22,78 | 23,02 | +1,05% | 1,83% | 6.497.600 |
| 18/06/1992 | 22,54 | 23,02 | 22,48 | 22,78 | +1,06% | 2,38% | 3.753.098 |
| 17/06/1992 | 22,96 | 23,14 | 22,48 | 22,54 | -3,08% | 2,86% | 5.631.742 |
| 16/06/1992 | 23,50 | 23,62 | 23,26 | 23,26 | -0,51% | 1,52% | 2.526.938 |
| 15/06/1992 | 23,32 | 23,80 | 23,20 | 23,38 | -0,51% | 2,56% | 2.334.944 |
| 12/06/1992 | 23,68 | 23,74 | 23,44 | 23,50 | +0,00% | 1,26% | 2.882.000 |
| 11/06/1992 | 22,96 | 23,62 | 22,78 | 23,50 | +2,60% | 3,64% | 4.990.995 |
| 10/06/1992 | 23,20 | 23,38 | 22,84 | 22,90 | -1,54% | 2,31% | 3.883.678 |
| 09/06/1992 | 23,44 | 23,50 | 23,14 | 23,26 | -0,76% | 1,53% | 3.062.885 |
| 08/06/1992 | 23,68 | 23,74 | 23,14 | 23,44 | -0,51% | 2,52% | 2.545.382 |
| 05/06/1992 | 23,80 | 23,97 | 23,20 | 23,56 | -1,00% | 3,26% | 4.132.474 |
| 04/06/1992 | 23,74 | 23,86 | 23,50 | 23,80 | +0,50% | 1,51% | 3.723.334 |
| 03/06/1992 | 23,86 | 24,15 | 23,68 | 23,68 | +0,00% | 2,00% | 5.017.405 |
| 02/06/1992 | 24,33 | 24,39 | 23,62 | 23,68 | -3,41% | 3,19% | 5.800.890 |
| 01/06/1992 | 23,86 | 24,51 | 23,62 | 24,51 | +1,99% | 3,75% | 4.443.939 |
| 29/05/1992 | 24,33 | 24,45 | 23,91 | 24,03 | -1,23% | 2,21% | 3.939.222 |
| 28/05/1992 | 23,44 | 24,33 | 23,38 | 24,33 | +3,03% | 4,07% | 3.624.613 |
| 27/05/1992 | 23,62 | 23,74 | 23,44 | 23,62 | -0,25% | 1,26% | 3.590.238 |
| 26/05/1992 | 24,27 | 24,27 | 23,50 | 23,68 | -2,46% | 3,19% | 4.962.699 |
| 22/05/1992 | 23,68 | 24,33 | 23,68 | 24,27 | +3,12% | 2,77% | 7.012.378 |
| 21/05/1992 | 23,38 | 23,60 | 23,38 | 23,54 | -0,25% | 0,94% | 4.597.157 |
| 20/05/1992 | 23,72 | 23,78 | 23,58 | 23,60 | -0,42% | 0,84% | 4.360.099 |
| 19/05/1992 | 23,22 | 23,82 | 23,18 | 23,70 | +2,32% | 2,74% | 5.937.130 |
| 18/05/1992 | 23,10 | 23,28 | 23,08 | 23,16 | +0,52% | 0,86% | 3.924.970 |
| 15/05/1992 | 23,06 | 23,18 | 23,02 | 23,04 | -0,69% | 0,69% | 6.623.779 |
| 14/05/1992 | 23,40 | 23,42 | 23,06 | 23,20 | -1,35% | 1,53% | 4.756.243 |
| 13/05/1992 | 23,56 | 23,60 | 23,40 | 23,52 | -0,08% | 0,84% | 3.030.816 |
| 12/05/1992 | 23,78 | 23,82 | 23,46 | 23,54 | -0,75% | 1,50% | 5.017.195 |